Checkpoint Therapeutics Inc’s recent filing unveils that its CEO, President and Director Oliviero James F III unloaded Company’s shares for reported $12142.0 on Feb 28 ’24. In the deal valued at $2.06 per share,5,894 shares were sold. As a result of this transaction, Oliviero James F III now holds 350,836 shares worth roughly $0.59 million.
Then, GRAY WILLIAM GARRETT sold 2,035 shares, generating $4,212 in total proceeds. Upon selling the shares at $2.07, the Chief Financial Officer now owns 145,224 shares.
Before that, Oliviero James F III sold 11,900 shares. Checkpoint Therapeutics Inc shares valued at $23,919 were divested by the CEO, President and Director at a price of $2.01 per share. As a result of the transaction, Oliviero James F III now holds 369,680 shares, worth roughly $0.62 million.
A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Cantor Fitzgerald began covering CKPT with “an Overweight” recommendation on January 20, 2021. Lake Street started covering the stock on May 29, 2019. It rated CKPT as “a Buy”.
Price Performance Review of CKPT
On Tuesday, Checkpoint Therapeutics Inc [NASDAQ:CKPT] saw its stock fall -1.74% to $1.69. Over the last five days, the stock has lost -7.65%. Checkpoint Therapeutics Inc shares have fallen nearly -26.20% since the year began. Nevertheless, the stocks have fallen -35.25% over the past one year. While a 52-week high of $3.62 was reached on 01/04/24, a 52-week low of $1.30 was recorded on 01/26/24. SMA at 50 days reached $1.9705, while 200 days put it at $2.1324. A total of 0.51 million shares were traded, compared to the trading of 0.27 million shares in the previous session.
Levels Of Support And Resistance For CKPT Stock
The 24-hour chart illustrates a support level at 1.6433, which if violated will result in even more drops to 1.5967. On the upside, there is a resistance level at 1.7533. A further resistance level may holdings at 1.8167. The Relative Strength Index (RSI) on the 14-day chart is 33.01, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1343, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.18%. Stochastics %K at 7.61% indicates the stock is a buying.
The most recent change occurred on December 08, 2017 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $11 price target.
